Report Detail
Cerebral and Pulse Oximeter Global Market - Forecast to 2026
- RnM3925073 |
- 12 March, 2020 |
- Global |
- 375 Pages |
- IQ4I Research & Consultancy |
- Medical Devices & Consumables
Cerebral and pulse oximeters are class of non-invasive medical devices used for monitoring of oxygen saturation in arterial and cerebral blood. These devices are mainly used for monitoring purposes in critical care, Operation rooms, general wards, home care settings, ambulatory surgical centers and in recreational activities where continuous monitoring of oxygen is required. Variation in oxygen level may leads to several complications such as hypoxia, Polycythemia, which is an increased production of red blood cells. Polycythemia increases the risk of clotting and can hurt brain function. Hence to prevent brain damage, heart failure and death continuous monitoring of oxygen level in blood is needed.
Cerebral and pulse oximeter global market is segmented on the basis of products, applications, end-users and geography. The products market is segmented into cerebral oximeter and pulse oximeter, among them pulse oximeter segment held the largest share of the market with xx% in 2019 and are expected to grow at a low single digit CAGR of %xx from 2019 to 2026 and Cerebral oximeter segment is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026. Pulse oximeters are further sub-segmented into Fingertip, handheld, table top and other pulse oximeters. The handheld pulse oximeter accounted for the largest share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Fingertip pulse oximeter is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Based on the products, pulse oximeters are further segmented into monitors and sensors. Among these, pulse oximeter sensors segment accounted for the largest share of xx% in 2019 and is expected to grow at a strong CAGR of xx% from 2019 to 2026. Pulse oximeter sensors are further segmented into reusable and disposable sensors, reusable sensors segment accounted for the largest share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Cerebral oximeters are segmented into cerebral oximeter monitor and cerebral oximeter sensors, among these cerebral oximeter sensors segment accounted for the largest share of xx% in 2019 and is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026. Cerebral oximeter sensors are further segmented into single emitter dual detector, dual emitter dual detector, four emitter dual detector, five emitter dual detector and others. Among these, single emitter dual detector accounted for the largest share of xx% in 2019 and is expected to grow at a mid single digit CAGR of x% from 2019 to 2026. Five emitter dual detectors segment is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026.
Applications are segmented into monitoring and surgeries, among them, monitoring segment held the largest share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Surgeries segment is expected to be the fastest growing segment with mid single digit CAGR xx% from 2019 to 2026.
End-users are classified into hospitals, ambulatory surgical centers, home healthcare and others. Among them, hospitals segment commanded the largest segmental share of xx% in 2019 and is expected to be the fastest growing segment with a low single digit CAGR of xx% from 2019 to 2026. Hospitals are further segmented into operation theater, ICU, general ward and others, General ward was the largest segment commanding a share of xx% in 2019 and is expected to grow at a low single digit CAGR of xx% from 2019 to 2026. Operation room segment is expected to grow at a strong mid single digit CAGR of xx% from 2019 to 2026.
Geographically, North America is the largest market, with a share of xx% followed by Europe and Asia Pacific. The APAC region is the fastest growing region and is expected to grow at a mid single digit CAGR of xx% from 2019 to 2026 presenting an array of opportunities for growth and is likely to get the attention of new investors in the cerebral and pulse oximeter market. Growth in the Asian market is attributed to rising prevalence of respiratory disorders and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The cerebral and pulse oximeter are expected to grow steadily at a low single digit CAGR of xx% from 2019 to 2026. Increase in incidence of respiratory and cardiovascular diseases, rising adoption in homecare settings, growing use of patient monitoring devices in hospitals and launch of convenient fingertip and wrist oximeters are the factors driving the market growth. The technological advancements and increase in new product approval are expected to offer potential opportunities.
However, various factors such as inaccuracy in results, skin integrity issues are limiting the growth of cerebral and pulse oximeter global market. The threats for the market include lack of awareness about the diseases in emerging countries and stringent regulatory requirements for new products.
The cerebral and pulse oximeter global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Major players in cerebral and pulse oximeter market include Masimo Corporation (Switzerland), Medtronic PLC. (Ireland), Koninklijke Philips N.V. (Netherlands), GE healthcare (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden (Japan), Smiths Medical (U.S.), Nonin Medical Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), RossMax International Inc. (U.S.) and Heal Force Bio-meditech Holdings Limited (China).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Rest of North America
• Europe
o Germany
o Italy
o France
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Rest of APAC
• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle East and Others
1 EXECUTIVE SUMMARY 23
2 INTRODUCTION 29
- 2.1 KEY TAKEAWAYS 29
- 2.2 SCOPE OF THE REPORT 29
- 2.3 REPORT DESCRIPTION 30
- 2.4 MARKETS COVERED 32
- 2.5 STAKEHOLDERS 34
- 2.6 RESEARCH METHODOLOGY 34
- 2.6.1 MARKET SIZE ESTIMATION 36
- 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 39
- 2.6.3 SECONDARY SOURCES 40
- 2.6.4 PRIMARY SOURCES 40
- 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 41
- 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 42
- 2.6.7 ASSUMPTIONS 42
3 MARKET ANALYSIS 46
- 3.1 INTRODUCTION 46
- 3.2 MARKET SEGMENTATION 47
- 3.3 FACTORS INFLUENCING MARKET 49
- 3.3.1 DRIVERS AND OPPORTUNITIES 49
- 3.3.1.1 Increase in incidence of cardiac and respiratory disorders 49
- 3.3.1.2 Technological advancements 51
- 3.3.1.3 Increase in hospitalization and surgeries 51
- 3.3.1.4 Increase in demand for pulse oximeters in homecare settings and recreational activities. 52
- 3.3.2 RESTRAINTS AND THREATS 54
- 3.3.2.1 Inaccuracy of results 54
- 3.3.2.2 Skin integrity issues 55
- 3.3.2.3 Lack of awareness of the disease 56
- 3.3.2.4 Stringent regulatory requirements for new products 57
- 3.3.1 DRIVERS AND OPPORTUNITIES 49
- 3.4 REGULATORY AFFAIRS 58
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 59
- 3.4.1.1 ISO 9001: 2015 Quality Management System 59
- 3.4.1.2 ISO 13485 Medical Devices 59
- 3.4.2 U.S. 60
- 3.4.3 CANADA 60
- 3.4.4 EUROPE 61
- 3.4.5 INDIA 62
- 3.4.6 CHINA 63
- 3.4.7 JAPAN 64
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 59
- 3.5 TECHNOLOGICAL ADVANCEMENTS 65
- 3.5.1 INTRODUCTION 65
- 3.5.2 HIGH RESOLUTION PULSE OXIMETRY 65
- 3.5.3 ORGANIC LED’S IN PULSE OXIMETER 66
- 3.5.4 PULSE OXIMETERS PREVENTION OF RESPIRATORY ARREST AND DEATH DUE TO OPIOIDS OVERDOSE 66
- 3.5.5 RETINAL OXIMETRY 67
- 3.6 PORTER’S FIVE FORCE ANALYSIS 68
- 3.6.1 THREAT OF NEW ENTRANTS 69
- 3.6.2 THREAT OF SUBSTITUTES 69
- 3.6.3 RIVALRY AMONG EXISTING COMPETITORS 69
- 3.6.4 BARGAINING POWER OF SUPPLIERS 70
- 3.6.5 BARGAINING POWER OF BUYERS 70
- 3.7 SUPPLY CHAIN ANALYSIS 71
- 3.8 MARKET SHARE ANALYSIS 74
- 3.8.1 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET SHARE ANALYSIS 74
- 3.8.2 CEREBRAL OXIMETER MARKET SHARE ANALYSIS 77
- 3.8.3 PULSE OXIMETER MARKET SHARE ANALYSIS 79
- 3.8.4 FINGERTIP MARKET SHARE ANALYSIS 81
- 3.8.5 HANDHELD MARKET SHARE ANALYSIS 83
- 3.8.6 TABLETOP MARKET SHARE ANALYSIS 85
- 3.8.7 OTHERS MARKET SHARE ANALYSIS 87
- 3.9 OXIMETER PRODUCT APPROVALS 89
- 3.10 REIMBURSEMENT SCENARIO 94
- 3.11 ADULT V/S NEONATAL/PEDIATRIC CEREBRAL AND PULSE OXIMETER 97
- 3.12 CEREBRAL OXIMETR UNITS SOLD AND INSTALLED BASE AND MARKET PENETRATION 98
- 3.12.1 CEREBRAL OXIMETER UNITS SOLD AND INSTALLED BASE
BY END-USER 99
- 3.13 PULSE OXIMETERS UNITS SOLD AND INSTALLED BASE 100
- 3.13.1 PULSE OXIMETER UNITS SOLD AND INSTALLED BASE BY END-USER 105
4 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET, BY PRODUCT 108
- 4.1 INTRODUCTION 108
- 4.2 CEREBRAL OXIMETER 110
- 4.2.1 CEREBRAL OXIMETER MONITOR 113
- 4.2.2 CEREBRAL OXIMETER SENSORS 115
- 4.2.2.1 Single emitter dual detector 117
- 4.2.2.2 Dual emitter dual detector 119
- 4.2.2.3 Four emitter dual detector 120
- 4.2.2.4 Five emitter dual detector 121
- 4.2.2.5 Other sensors 122
- 4.3 PULSE OXIMETER 124
- 4.3.1 PULSE OXIMETER DEVICES 125
- 4.3.1.1 Fingertip pulse oximeters 128
- 4.3.1.2 Handheld pulse oximeters 132
- 4.3.1.3 Tabletop pulse oximeters 134
- 4.3.1.4 Others 136
- 4.3.2 PULSE OXIMETER BY PRODUCTS 138
- 4.3.2.1 Pulse oximeter monitors 140
- 4.3.2.2 Pulse oximeter sensors 142
- 4.3.2.2.1 Reusable sensors 145
- 4.3.2.2.2 Disposable sensors 147
5 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET, BY APPLICATION 149
- 5.1 INTRODUCTION 149
- 5.2 SURGERIES 151
- 5.3 MONITORING 155
6 CEREBRAL AND PULSE OXIMETER GLOBAL MARKET, BY END-USERS 160
- 6.1 INTRODUCTION 160
- 6.2 HOSPITALS 163
- 6.2.1 OPERATION ROOMS 165
- 6.2.2 INTENSIVE CARE UNIT 166
- 6.2.2.1 Neonatal intensive care unit 169
- 6.2.2.2 Adult intensive care unit 170
- 6.2.3 GENERAL WARDS 171
- 6.2.4 OTHER HOSPITAL CARE SETTINGS 173
- 6.3 AMBULATORY SURGICAL CENTERS 175
- 6.4 HOME HEALTHCARE 176
- 6.5 OTHERS (SLEEP CENTERS, RECREATIONAL ACTIVITIES, CLINICS/PHYSICIAN OFFICES, HOSPICES) 179
7 CEREBRAL AND PULSE OXIMETER MARKET BY REGION 181
- 7.1 INTRODUCTION 181
- 7.2 NORTH AMERICA 185
- 7.2.1 U.S. 210
- 7.2.2 REST OF NORTH AMERICA 212
- 7.3 EUROPE 215
- 7.3.1 GERMANY 240
- 7.3.2 FRANCE 243
- 7.3.3 ITALY 245
- 7.3.4 REST OF EUROPE 247
- 7.4 APAC 249
- 7.4.1 JAPAN 274
- 7.4.2 CHINA 277
- 7.4.3 INDIA 279
- 7.4.4 REST OF APAC 281
- 7.5 ROW 283
- 7.5.1 BRAZIL 307
- 7.5.2 REST OF LATAM 310
- 7.5.3 MIDDLE EAST AND OTHERS 311
8 COMPETITIVE LANDSCAPE 314
- 8.1 INTRODUCTION 314
- 8.2 APPROVALS 315
- 8.3 AGREEMENTS 318
- 8.4 ACQUISITION 318
9 MAJOR COMPANIES 320
- 9.1 EDWARDS LIFESCIENCES CORPORATION. 320
- 9.1.1 OVERVIEW 320
- 9.1.2 FINANCIALS 321
- 9.1.3 PRODUCT PORTFOLIO 323
- 9.1.4 KEY DEVELOPMENTS 323
- 9.1.5 BUSINESS STRATEGY 324
- 9.1.6 SWOT ANALYSIS 325
- 9.2 GE HEALTHCARE 326
- 9.2.1 OVERVIEW 326
- 9.2.2 FINANCIALS 327
- 9.2.3 PRODUCT PORTFOLIO 330
- 9.2.4 KEY DEVELOPMENTS 330
- 9.2.5 BUSINESS STRATEGY 330
- 9.2.6 SWOT ANALYSIS 331
- 9.3 HEAL-FORCE BIO-MEDITECH HOLDINGS LIMITED. 332
- 9.3.1 OVERVIEW 332
- 9.3.2 FINANCIALS 332
- 9.3.3 PRODUCT PORTFOLIO 333
- 9.3.4 KEY DEVELOPMENTS 333
- 9.3.5 BUSINESS STRATEGY 333
- 9.3.6 SWOT ANALYSIS 334
- 9.4 KONINKLIJKE PHILIPS N.V. 335
- 9.4.1 OVERVIEW 335
- 9.4.3 PRODUCT PORTFOLIO 338
- 9.4.4 KEY DEVELOPMENTS 339
- 9.4.5 BUSINESS STRATEGY 339
- 9.4.6 SWOT ANALYSIS 340
- 9.5 MASIMO CORPORATION 341
- 9.5.1 OVERVIEW 341
- 9.5.2 FINANCIALS 342
- 9.5.3 PRODUCT PORTFOLIO 344
- 9.5.4 KEY DEVELOPMENTS 345
- 9.5.5 BUSINESS STRATEGY 346
- 9.5.6 SWOT ANALYSIS 347
- 9.6 MEDTRONIC PLC 348
- 9.6.1 OVERVIEW 348
- 9.6.2 FINANCIALS 349
- 9.6.3 PRODUCT PORTFOLIO 353
- 9.6.4 KEY DEVELOPMENTS 353
- 9.6.5 BUSINESS STRATEGY 354
- 9.6.6 SWOT ANALYSIS 354
- 9.7 NIHON KOHEDEN CORPORATION. 355
- 9.7.1 OVERVIEW 355
- 9.7.2 FINANCIALS 356
- 9.7.3 PRODUCT PORTFOLIO 358
- 9.7.4 KEY DEVELOPMENTS 359
- 9.7.5 BUSINESS STRATEGY 359
- 9.7.6 SWOT ANALYSIS 359
- 9.8 NONIN MEDICAL INC. 360
- 9.8.1 OVERVIEW 360
- 9.8.2 FINANCIALS 361
- 9.8.3 PRODUCT PORTFOLIO 361
- 9.8.4 KEY DEVELOPMENTS 362
- 9.8.5 BUSINESS STRATEGY 363
- 9.8.6 SWOT ANALYSIS 363
- 9.9 ROSSMAX INTERNATIONAL LTD. 364
- 9.9.1 OVERVIEW 364
- 9.9.2 FINANCIALS 365
- 9.9.3 PRODUCT PORTFOLIO 365
- 9.9.4 KEY DEVELOPMENTS 365
- 9.9.5 BUSINESS STRATEGY 365
- 9.9.6 SWOT ANALYSIS 366
- 9.10 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONIC CO., LTD. 367
- 9.10.1 OVERVIEW 367
- 9.10.2 FINANCIALS 368
- 9.10.3 PRODUCT PORTFOLIO 368
- 9.10.4 KEY DEVELOPMENTS 368
- 9.10.5 BUSINESS STRATEGY 368
- 9.10.6 SWOT ANALYSIS 369
- 9.11 SMITHS MEDICAL 370
- 9.11.1 OVERVIEW 370
- 9.11.2 FINANCIALS 371
- 9.11.3 PRODUCT PORTFOLIO 373
- 9.11.4 KEY DEVELOPMENTS 373
- 9.11.5 BUSINESS STRATEGY 373
- 4.3.1 PULSE OXIMETER DEVICES 125
Summary:
Get latest Market Research Reports on Cerebral and Pulse Oximeter. Industry analysis & Market Report on Cerebral and Pulse Oximeter is a syndicated market report, published as Cerebral and Pulse Oximeter Global Market - Forecast to 2026. It is complete Research Study and Industry Analysis of Cerebral and Pulse Oximeter market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
